We give you the straight poop on wastewater monitoring for CV-19.
Read More
I do my best Ann Landers or Dear Abby, or whomever the current epitome of social grace is, in regard to Dr. Fauci's encounter with the Dread Virus CV-19.
Read More
Hard not to be obsessed with the extremely tenuous and dangerous situation our country finds itself in.
Read More
A mid-week drop of research summaries to boost your flagging interest in the epidemic, which is completely justified.
Read More
Over the last two decades the pharmacy benefit manager industry got very large, very consolidated and engaged in abusive and deceptive pricing practices. Ultimate payers generally don't trust the current mix of PBMs so we are seeing a new wave of entrants promising a different, more transparent business model. Capital Rx is building new claims and other software to support PBMs and has added a fresh $106 million in financing.
https://www.fiercehealthcare.com/payers/capital-rx-rakes-106m-funding-round-it-continues-build-out-judi-platformIt is not clear that increasing levels of CO2 drive increased temperature, in fact the relationship may go the other way.
Read More
In the oldest age group, boosters have modest protection against serious disease and infection.
Read More
The late middle age group displays a similar pattern of limited infection protection from vax, but some protection against serious disease.
Read More
In the 18 to 49 year old group, being boosted doesn't stop infection, but may prevent hospitalization.
Read More
Breakthrough events in older children, where at this point vax provides no protection against infection or hospitalization.
Read More
The first age group chart covers 5 to 11 year olds, where vax provides less than zero protection against infection.
Read More